INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 112 filers reported holding INSYS THERAPEUTICS INC NEW in Q4 2017. The put-call ratio across all filers is 1.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $41,000 | -86.4% | 8,978 | -89.6% | 0.00% | – |
| Q4 2018 | $302,000 | +263.9% | 86,352 | +953.6% | 0.00% | – |
| Q3 2018 | $83,000 | +56.6% | 8,196 | +13.8% | 0.00% | – |
| Q2 2018 | $53,000 | -65.8% | 7,200 | -71.9% | 0.00% | – |
| Q1 2018 | $155,000 | +154.1% | 25,624 | +303.5% | 0.00% | – |
| Q4 2017 | $61,000 | -88.0% | 6,351 | -89.0% | 0.00% | – |
| Q3 2017 | $508,000 | -24.6% | 57,554 | +7.9% | 0.00% | – |
| Q2 2017 | $674,000 | +40.4% | 53,323 | +16.7% | 0.00% | – |
| Q1 2017 | $480,000 | +57.4% | 45,694 | +37.9% | 0.00% | – |
| Q4 2016 | $305,000 | – | 33,133 | +87092.1% | 0.00% | – |
| Q3 2016 | $0 | -100.0% | 38 | -56.8% | 0.00% | – |
| Q2 2016 | $1,000 | -66.7% | 88 | -57.5% | 0.00% | – |
| Q1 2016 | $3,000 | -100.0% | 207 | -99.9% | 0.00% | -100.0% |
| Q4 2015 | $6,522,000 | -24.6% | 227,819 | -25.0% | 0.00% | 0.0% |
| Q3 2015 | $8,650,000 | +2.4% | 303,917 | +29.2% | 0.00% | 0.0% |
| Q2 2015 | $8,447,000 | +131.5% | 235,146 | +274.6% | 0.00% | +100.0% |
| Q1 2015 | $3,649,000 | +507.2% | 62,779 | +339.8% | 0.00% | – |
| Q4 2014 | $601,000 | -89.4% | 14,274 | -91.2% | 0.00% | -100.0% |
| Q3 2013 | $5,653,000 | +5.7% | 161,548 | -58.2% | 0.00% | 0.0% |
| Q2 2013 | $5,349,000 | – | 386,529 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |